Sorry, you need to enable JavaScript to visit this website.

Featured Stories

Then vs. Now: Molecular Design

Developing a new medicine starts at the most fundamental level: understanding how disease works. That often means looking beyond what we can observe directly and studying how molecules interact with biological targets.

Black-and-white photo of a scientist holding a wireframe molecular model

June Social Media Round-Up—2025 Impact Report, ADA 2026, and More

School is out for the summer, but Pfizer colleagues are still hard at work. Check out the June social media round up, where we share the latest updates and highlights.

Photograph of two CNBC hosts seated at a news desk in an elegant studio thumbnail

A Prostate Cancer Survivor Shares the Importance of Early Detection—and Why Knowing Your History, Monitoring PSA and Talking to Your Doctor Matters

For years, senior oncology account specialist Dan Morgan has helped doctors understand what Pfizer medications can do for cancer patients. In 2024, the script flipped when he became a patient himself. Thanks to his work, Dan knew just how to advocate for his health by requesting blood tests and diagnostic exams, and his prostate cancer was detected early, before he even felt sick.

Graphic of many pink microscopic cells floating against a dark background thumbnail

Press Releases

Categories

Keywords

  • All Keywords

March 2026

February 2026

Resource Library

Resource Library

Press Kits

These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.

View Press Kits Details
Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.

For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.

For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".

For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.

Contact Pfizer Media Relations

Media Contacts

Media Contacts

United States, Canada, and Latin America
+1 212.733.1226

Europe, Middle East, and Africa
+44-(0)845.300.8033

Asia Pacific
+65.918.732.47

Email
[email protected]